More details, including speakers will be announced shortly
- Registration/Badge collecting
- Special Feature Talk
- Welcome Reception
Session 1: The Cutting Edge—Surgical Innovations In Glaucoma
- 2.1 The Latest MIGS Targeting the Meshwork (iStent, Hydrus)
- 2.2 Expanding and Opening the Canal (GATT, OMNI, iTrack, Tanito hook, KDB, etc)
- 2.3 New and Improved Tubes and Trabs
- 2.4 Minimally Invasive Bleb Surgeries (PreserFlo, XEN, etc)—Better than Trab?
- 2.5 In Development: Future MIGS in the Pipeline
- 2.6 Suprachoroidal Shunts (iSTAR MINIject, AlloFlo, Ciliatech)
- 2.7 Panel + Q&A
Session 2: New Medications and Those on the Horizon
- 2.8 Omidenepag—PGA efficacy without the cosmetic/orbital effects?
- 2.9 Rhopressa—Targeting the Disease Site in Glaucoma?
- 2.10 Episcleral Venous Pressure—Relieving the Pressure Downstream (or Dropping the Floor on IOP)
- 2.11 Coming Soon—The New Pharma Targets
- 2.12 Panel + Q&A
Session 3: Advances in Laser Technology for Glaucoma
- 2.13 DSLT—Is It a Real Game Changer in the Clinic?
- 2.14 Cyclophotocoagulation— Is this MIGS Plus?
- 2.15 Perspectives on When and Where Laser Applies to Angle Closure?
- 2.16 Excimer Laser Trabeculostomy—Better than Other MIGS?
- 2.17 Panel + Q&A
Session 4: Diagnostics
- 2.18 Enhanced Glaucoma Detection with Cutting Edge OCT Technologies
- 2.19 High Resolution ASOCT and Anterior Segment Imaging
- 2.20 Next Generation VF Algorithms
- 2.21 Virtual Reality Perimetry and New Goggles
- 2.22 Artificial Intelligence in Detecting and Tracking Glaucoma
- 2.23 Do we need home IOP monitoring in glaucoma care?
- 2.23 Panel + Q&A
Session 5: Beyond IOP—How Can We Provide Help to the Optic Nerve
- 3.1 Neuroprotection – What Works, What Doesn’t, and Why the Gaps Persist
- 3.2 Pie in the Sky – Breakthrough Technologies and Unconventional Therapeutic Targets
- 3.3 Stem Cells for Glaucoma—How Can We Get Through the Roadblocks?
- 3.4 Alternative Approaches to Fixing the IOP and Nerve
- 3.5 NAD precursors — What Form and How Much
- 3.6 Electrify the Optic Nerve? – Bioengineering Approaches to Energize Optic Nerve Regeneration and Protection
- 3.7 How to Design Neuroprotection Trials?
- 3.8 Panel + Q&A
Session 6: Fresh from the Industry
- (Talks to be announced)